Free Trial

MeiraGTx (MGTX) Stock Price, News & Analysis

MeiraGTx logo
$8.62 +0.22 (+2.57%)
As of 10:35 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About MeiraGTx Stock (NASDAQ:MGTX)

Advanced

Key Stats

Today's Range
$8.43
$8.65
50-Day Range
$7.30
$8.40
52-Week Range
$3.97
$8.98
Volume
36,858 shs
Average Volume
495,504 shs
Market Capitalization
$693.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.00
Consensus Rating
Buy

Company Overview

MeiraGTx Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
86th Percentile Overall Score

MGTX MarketRank™: 

MeiraGTx scored higher than 86% of companies evaluated by MarketBeat, and ranked 147th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MeiraGTx has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Upside Potential

    MeiraGTx has a consensus price target of $24.00, representing about 180.1% upside from its current price of $8.57.

  • Amount of Analyst Coverage

    MeiraGTx has only been the subject of 1 research reports in the past 90 days.

  • Read more about MeiraGTx's stock forecast and price target.
  • Earnings Growth

    Earnings for MeiraGTx are expected to grow in the coming year, from ($1.48) to $0.38 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MeiraGTx is -4.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MeiraGTx is -4.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MeiraGTx has a P/B Ratio of 9.85. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MeiraGTx's valuation and earnings.
  • Percentage of Shares Shorted

    4.59% of the outstanding shares of MeiraGTx have been sold short.
  • Short Interest Ratio / Days to Cover

    MeiraGTx has a short interest ratio ("days to cover") of 8.
  • Change versus previous month

    Short interest in MeiraGTx has recently increased by 5.43%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    MeiraGTx does not currently pay a dividend.

  • Dividend Growth

    MeiraGTx does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.59% of the outstanding shares of MeiraGTx have been sold short.
  • Short Interest Ratio / Days to Cover

    MeiraGTx has a short interest ratio ("days to cover") of 8.
  • Change versus previous month

    Short interest in MeiraGTx has recently increased by 5.43%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    MeiraGTx has a news sentiment score of 1.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.
  • Search Interest

    6 people have searched for MGTX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MeiraGTx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $583,055.00 in company stock.

  • Percentage Held by Insiders

    Only 7.50% of the stock of MeiraGTx is held by insiders.

  • Percentage Held by Institutions

    67.48% of the stock of MeiraGTx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MeiraGTx's insider trading history.
Receive MGTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MeiraGTx and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MGTX Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
See More Headlines

MGTX Stock Analysis - Frequently Asked Questions

MeiraGTx's stock was trading at $6.09 on January 1st, 2025. Since then, MGTX shares have increased by 40.7% and is now trading at $8.5690.

MeiraGTx Holdings PLC (NASDAQ:MGTX) announced its quarterly earnings data on Thursday, August, 14th. The company reported ($0.48) earnings per share for the quarter, beating analysts' consensus estimates of ($0.52) by $0.04. The firm earned $3.69 million during the quarter, compared to analysts' expectations of $8 million. MeiraGTx had a negative net margin of 415.39% and a negative trailing twelve-month return on equity of 314.44%.

MeiraGTx (MGTX) raised $75 million in an initial public offering (IPO) on Friday, June 8th 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch, Barclays and Evercore ISI acted as the underwriters for the IPO and Chardan was co-manager.

Shares of MGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MeiraGTx investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Moderna (MRNA).

Company Calendar

Last Earnings
8/14/2025
Today
10/03/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MGTX
CIK
1735438
Fax
N/A
Employees
300
Year Founded
2015

Price Target and Rating

High Price Target
$35.00
Low Price Target
$13.00
Potential Upside/Downside
+185.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$147.79 million
Net Margins
-415.39%
Pretax Margin
-415.39%
Return on Equity
-314.44%
Return on Assets
-63.28%

Debt

Debt-to-Equity Ratio
26.29
Current Ratio
0.88
Quick Ratio
0.88

Sales & Book Value

Annual Sales
$33.28 million
Price / Sales
20.31
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.87 per share
Price / Book
9.66

Miscellaneous

Outstanding Shares
80,450,000
Free Float
74,413,000
Market Cap
$675.78 million
Optionable
Optionable
Beta
1.34

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:MGTX) was last updated on 10/3/2025 by MarketBeat.com Staff
From Our Partners